Shridar Ganesan

X chromosomal abnormalities in basal-like human breast cancer.

Shridar Ganesan, Xin Lu, Myles Brown, 2006, Cancer cell.

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

L. Wessels, G. Abou-Alfa, Siraj M. Ali, 2022, Nature.

Portraits of breast cancer progression

Jill P. Mesirov, Gabriela Alexe, Gyan Bhanot, 2007, BMC Bioinformatics.

Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC

S. Jha, S. Abdulkadir, S. Gohel, 2024, Nature communications.

Loss of 53 BP 1 causes PARP inhibitor resistance in BRCA 1-mutated mouse mammary tumors

Shridar Ganesan, James H. Doroshow, S. Ganesan, 2012 .